ROCKVILLE, MD and SHENZHEN, CHINA, January 11, 2023 — HighTide Therapeutics Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases,
January 11, 2023
Learn more
ROCKVILLE, MD and SHENZHEN, CHINA,January 5, 2023— HighTide Therapeutics Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases,
January 05, 2023
Learn more
ROCKVILLE, MD and SHENZHEN, CHINA, November 16, 2022 — HighTide Therapeutics, Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive disease
November 17, 2022
Learn more
We will contact you as soon as possible
© 2020 HighTide Therapeutics Inc.
Follow Us
